GlaxoSmithKline in deal to develop microRNA-targeted therapeutics

GlaxoSmithKline said that it has entered into an alliance with the California-based Regulus Therapeutics LLC to discover and develop microRNA-targeted therapeutics to treat inflammatory diseases.